Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

It is estimated that 200 million people have suffered the infection with schistosomes in the world. The fact that treatment of schistosomiasis only relies on a single drug praziquantel does not adapt to the demand. Although praziquantel exhibits excellent therapeutic efficacy, it shows no preventive action to the infection. Therefore, development of new anti-schistosomal drugs has been received serious attention. In this paper the recent development of new antischistosomal drugs such as oxadiazole-2-oxides, mefloquine, etc. has been reviewed, and the process of their development and anti-schistosomal properties recounted.


Shu-Hua Xiao. Progress in development of new antischistosomal drugs in recent years]. Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi = Chinese journal of parasitology & parasitic diseases. 2010 Jun 30;28(3):218-25

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 20806509

View Full Text